{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T19:20:31Z","timestamp":1794856831851,"version":"4.9.1"},"reference-count":10,"publisher":"American Society of Hematology","issue":"22","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,11,23]]},"DOI":"10.1182\/bloodadvances.2021004190","type":"journal-article","created":{"date-parts":[[2021,8,30]],"date-time":"2021-08-30T22:58:03Z","timestamp":1630364283000},"page":"4630-4633","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":16,"title":["Assessment and reporting of quality-of-life measures in pivotal clinical trials of hematological malignancies"],"prefix":"10.1182","volume":"5","author":[{"given":"Samer","family":"Al Hadidi","sequence":"first","affiliation":[{"name":"The Center for Cell and Gene Therapy, Department of Hematology and Oncology;"},{"name":"Myeloma Center, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, AZ; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rammurti T.","family":"Kamble","sequence":"additional","affiliation":[{"name":"The Center for Cell and Gene Therapy, Department of Hematology and Oncology;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Carrum","sequence":"additional","affiliation":[{"name":"The Center for Cell and Gene Therapy, Department of Hematology and Oncology;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen E.","family":"Heslop","sequence":"additional","affiliation":[{"name":"The Center for Cell and Gene Therapy, Department of Hematology and Oncology;"},{"name":"Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Texas Children\u2019s Hospital and Houston Methodist Hospital, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4004-7837","authenticated-orcid":false,"given":"Carlos Almeida","family":"Ramos","sequence":"additional","affiliation":[{"name":"The Center for Cell and Gene Therapy, Department of Hematology and Oncology;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2021,11,17]]},"reference":[{"issue":"4","key":"2021111716204039800_B1","doi-asserted-by":"crossref","first-page":"e305","DOI":"10.1038\/bcj.2015.29","article-title":"Haematological cancer and quality of life: a systematic literature review","volume":"5","author":"Allart-Vorelli","year":"2015","journal-title":"Blood Cancer J."},{"issue":"2","key":"2021111716204039800_B2","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1177\/1758834010395342","article-title":"Health-related quality of life and cancer clinical trials","volume":"3","author":"Osoba","year":"2011","journal-title":"Ther Adv Med Oncol."},{"issue":"1","key":"2021111716204039800_B3","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1477-7525-4-79","article-title":"Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance","volume":"4","author":"US Department of Health and Human Services FDA Center for Drug Evaluation and Research, US Department of Health and Human Services FDA Center for Biologics Evaluation and Research, US Department of Health and Human Services FDA Center for Devices and Radiological Health","year":"2006","journal-title":"Health Qual Life Outcomes."},{"key":"2021111716204039800_B4","author":"US Food and Drug Administration"},{"issue":"3","key":"2021111716204039800_B5","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/ejh.13104","article-title":"Quality of life in survivors of hematological malignancies stratified by cancer type, time since diagnosis and stem cell transplantation","volume":"101","author":"Esser","year":"2018","journal-title":"Eur J Haematol."},{"key":"2021111716204039800_B6","doi-asserted-by":"crossref","first-page":"j4530","DOI":"10.1136\/bmj.j4530","article-title":"Availability of evidence of benefits on overall survival and quality of life of cancer drugs approved by European Medicines Agency: retrospective cohort study of drug approvals 2009-13","volume":"359","author":"Davis","year":"2017","journal-title":"BMJ."},{"issue":"3","key":"2021111716204039800_B7","doi-asserted-by":"crossref","first-page":"e200363","DOI":"10.1001\/jamanetworkopen.2020.0363","article-title":"Patient experience captured by quality-of-life measurement in oncology clinical trials","volume":"3","author":"Haslam","year":"2020","journal-title":"JAMA Netw Open."},{"issue":"5","key":"2021111716204039800_B8","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","article-title":"The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology","volume":"85","author":"Aaronson","year":"1993","journal-title":"J Natl Cancer Inst."},{"key":"2021111716204039800_B9","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.3389\/fphar.2020.01308","article-title":"Hematological Malignancy Specific Patient-Reported Outcome Measure (HM-PRO): construct validity study","volume":"11","author":"Goswami","year":"2020","journal-title":"Front Pharmacol."},{"issue":"8","key":"2021111716204039800_B10","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.jval.2012.08.2210","article-title":"Measuring health-related quality of life in leukemia: the Functional Assessment of Cancer Therapy--Leukemia (FACT-Leu) questionnaire","volume":"15","author":"Cella","year":"2012","journal-title":"Value Health."}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/5\/22\/4630\/1835631\/advancesadv2021004190.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/5\/22\/4630\/1835631\/advancesadv2021004190.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T17:00:27Z","timestamp":1637168427000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/5\/22\/4630\/476717\/Assessment-and-reporting-of-quality-of-life"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,17]]},"references-count":10,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2021,11,23]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2021004190","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,17]]}}}